Mira Pharmaceuticals Inc (MIRA) concluded trading on Wednesday at a closing price of $0.92, with 4.78 million shares of worth about $4.39 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.27% during that period and on April 23, 2025 the price saw a gain of about 7.08%. Currently the company’s common shares owned by public are about 16.56M shares, out of which, 12.48M shares are available for trading.
Stock saw a price change of 2.65% in past 5 days and over the past one month there was a price change of -25.12%. Year-to-date (YTD), MIRA shares are showing a performance of -19.21% which increased to 10.75% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.51 but also hit the highest price of $5.01 during that period. The average intraday trading volume for Mira Pharmaceuticals Inc shares is 1.06 million. The stock is currently trading -0.73% below its 20-day simple moving average (SMA20), while that difference is down -10.43% for SMA50 and it goes to -30.70% lower than SMA200.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) currently have 16.56M outstanding shares and institutions hold larger chunk of about 7.13% of that.
The stock has a current market capitalization of $15.48M and its 3Y-monthly beta is at 2.11. It has posted earnings per share of -$0.48 in the same period. It has Quick Ratio of 3.99 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MIRA, volatility over the week remained 17.16% while standing at 10.30% over the month.
Stock’s fiscal year EPS is expected to rise by 14.29% while it is estimated to increase by 14.44% in next year.
